Science News Roundup: Sanofi partners with AI firm Exscientia to develop up to 15 new drugs; Japan billionaire Maezawa: going to space makes you obsessed with Earth

The 46-year-old fashion magnate and art collector in December became the first space tourist on the International Space Station in over a decade, preparation for a more ambitious trip around the moon with Elon Musk's SpaceX planned for 2023.

Following is a summary of current science news briefs.

Sanofi partners with AI firm Exscientia to develop up to 15 new drugs

French drugmaker Sanofi SA will partner with British AI firm Exscientia Plc to develop up to 15 drug candidates across oncology and immunology, in a deal worth up to $5.2 billion in milestone payments, the two companies said on Friday. Exscientia will get an upfront cash payment of $100 million, leading discovery and design of small molecule drugs up to nomination of the candidate most likely to be viable. After that, Sanofi will take charge of clinical development.

Japan billionaire Maezawa: going to space makes you obsessed with Earth

Japanese billionaire Yusaku Maezawa, newly returned to Japan after a 12-day journey into space last month, said being launched into the cosmos was less scary than riding a rollercoaster and made him obsessed with Earth. The 46-year-old fashion magnate and art collector in December became the first space tourist on the International Space Station in over a decade, preparation for a more ambitious trip around the moon with Elon Musk's SpaceX planned for 2023.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)